Immix Biopharma Completes $150 Million Stock Offering
Immix Biopharma has completed a registered underwritten offering of 16.78 million shares at $8.94 per share, raising approximately $140.65 million in net proceeds after expenses. The financing includes participation from leading U.S. biotechnology institutional investors and mutual funds.
Topics: Biopharma Capital Markets Equity Offering